Please Wait...

Phase 1 Open House

March 22, 2018 - 1:00am (EDT)

We look forward to seeing you! Please complete the registration form below.

Bioclinica Research cordially invites you to tour our recently expanded clinical pharmacology unit and meet our team of experts.

It’s 5 o’clock somewhere – flip flops optional! Enjoy cocktails and heavy hors d'oeuvres on a beautiful spring, Florida evening set to the sounds of steel drums.

Thursday, March 22, 5:30 - 8:00 p.m.
100 West Gore Street, Suite 202
Orlando, FL 32806

Transportation provided to and from ASCPT – see registration form at right for booking details

Get a sneak peek of our recently expanded Phase 1 unit


Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

Bioclinica Delivers Individual Case Safety Report (ICSR) Processing w Quality & Consistency While Crossing One Mil…
bioclinica (Yesterday)
Who made the BioSpace list of 11 most innovative life sciences companies in the world? Ck it out here via @biospace…
bioclinica (Yesterday)
BREAKING: With a passion for Drug Safety, we’re delighted to share @bioclinica #pharmacovigilance crossed 1M ICSR c…
bioclinica (2 days ago)
RT @isciencebox: Draft and Final FDA Guidances Detail Development of New Drugs for Neurological Disorders @RAPSorg
bioclinica (2 days ago)
RT @RAPSorg: Final @US_FDA Rule Requires Medical Device Trials Outside US to Conform to GCP | #Regulatory Focus #FD…
bioclinica (2 days ago)
Congrats @bioclinica on @Clin_Info_News Best Practices Award 4 "Transformational Med. Imaging in #ClinicalTrials. '…
bioclinica (1 week ago)

Latest Blogs:

Latin America: Benefit from the Right Partner
Removing Risk from Clinical Trial Management System (CTMS) Implementations
Collaboration Between Clinical Operations and the Logistics and Supply Chain Teams is Key to Trial Success
The Value of Protocol Review
CTMS and RBM: Hot Topics at OCT Nordics in Copenhagen